Charla: Metabolic Liver Disease (NAFLD) and mental illness: Is obesity at the heart of the matter?

El grupo de investigación Ee12-HYGIA: Cuidados y factores condicionantes en salud organiza la siguiente charla:

• Título: Metabolic Liver Disease (NAFLD) and mental illness: Is obesity at the heart of the matter?
• Ponente: Karen L. Houseknecht, PhD. Associate Provost for Research and Scholarship. Professor of Pharmacology. University of New England. Fulbright Senior Scholar in Pharmacology. Universidad Autónoma de Madrid | UAM
• Resumen: Metabolic liver disease, also known as non-alcoholic fatty liver disease (NAFLD/NASH) is a growing public health epidemic, world-wide. The increased incidence of NAFLD parallels the global increase in obesity and insulin resistance. NAFLD is highly co-morbid with mental illness, however the mechanisms are not fully understood. My work focuses on understanding the role of psychiatric medications in the development of adverse endocrine and metabolic disorders including NAFLD.

La charla se realizará el jueves, 16 de marzo de 2023 de 12:00 a 13:30h en la Sala SUM de la Facultad de Ciencias de la Salud de la Universidad de Granada y se podrá seguir en formato presencial u online a través del siguiente enlace: https://meet.google.com/zmp-jopi-qbk

Acceso online